ASX
Mesoblast Limited
MSB:ASX•Healthcare
Sensitive ASX Announcement
FDA CLEARS PHASE 2 CLINICAL TRIAL FOR RHEUMATOID ARTHRITIS
Published: 30/01/13, 10:31am (AEST)•3 pages